-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In a new study, researchers from the University of Maryland School of Medicine and the Center for Regenerative Genetics have discovered a new genetic variant that is related to low-density lipoprotein (LDL) cholesterol and a type of low-density lipoprotein (LDL) cholesterol that damage the heart The lower level of a clotting protein called fibrinogen (FIB) is related, which seems to greatly reduce a person’s risk of heart disease
Scientists have long known about genetic mutations related to cholesterol levels
The researchers found that a missense variant of the gene B4GALT1 was associated with a decrease of nearly 14 mg/dL in LDL cholesterol and a decrease of nearly 30 mg/dL in FIB
Note: The original text has been deleted
Reference materials:
May E.